Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.32 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11892488 | 0.92 | KMT2A (0.37) | PDK2MAPTKIF11KMT2AATM | |
| Trifluoromethanesulfonic Acid SCHEMBL1992503 | 0.85 | PDK2 (0.36) | PDK2MAPTKIF11KMT2ACHRM5 | |
| SCHEMBL11892480 | 0.84 | KMT2A (0.42) | MAPTKMT2AMEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1989824 | 0.83 | PDK2 (0.44) | PDK2 | |
| SCHEMBL11892489 | 0.83 | MAPT (0.42) | PDK2MAPTKMT2AMEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1990043 | 0.83 | PDK2 (0.37) | PDK2MAPT | |
| Trifluoromethanesulfonic Acid SCHEMBL1992673 | 0.81 | PDK2 (0.35) | PDK2 | |
| Trifluoromethanesulfonic Acid SCHEMBL1995500 | 0.80 | PDK2 (0.39) | PDK2MAPTKMT2AMEN1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1990220 | 0.80 | PDK2 (0.43) | PDK2 | |
| SCHEMBL11892475 | 0.78 | KMT2A (0.42) | MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2186799-B1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORP (JP) | 2015-07-08 | — | — | EP | disclosed |
| US-8227624-B2 | Aromatic sulfonium salt compound | ADEKA CORPORATION (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110152540-A1 | AROMATIC SULFONIUM SALT COMPOUND | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| EP-2186799-A1 | AROMATIC SULFONIUM SALT COMPOUND | Adeka Corporation (JP) | 2010-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152540-A1 | AROMATIC SULFONIUM SALT COMPOUND | SLC43A1, SLC7A5, SPIN2B | PDK2 1881/4885MAPT 2042/4885KIF11 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.